Media

7 months ago

DemeRx NB Inc. Advances Study for Alcohol Use Disorder Treatment

4 months ago

Addressing the addiction and mental health crises in the United States

7 months ago

Ibogaine and Noribogaine: Mechanisms and Therapeutic Potential as Addiction Medicines

7 months ago

Exploring the Future of VR and Digital Therapeutics

7 months ago

The Unparalleled Power of Ibogaine in Addiction Recovery With Tom Feegel, CEO of Beond

7 months ago

Breaking the Cycle of Addiction with Ibogaine

7 months ago

Ibogaine Receives Serious Media Attention

7 months ago

Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction

7 months ago

Psychedelics Today Ep. 448: Deborah C. Mash, Ph.D. – Ibogaine, Noribogaine, and the Challenges of Federal Drug Policy

7 months ago

Opium Addiction Market expected to rise – BioCorRx Inc, Delpor Inc, DemeRx Inc, Alar Pharmaceuticals, expected to drive market

7 months ago

Advocates of using psychedelic drug ibogaine to treat addiction say its risks to the heart can be mitigated in a controlled study

7 months ago

Kentucky’s $42 million allocation for psychedelics research for opioid addiction

7 months ago

Rewiring an Addicted Brain | Deborah Mash – The Lindsey Elmore Show (podcast)

7 months ago

Are Psychedelics The Solution To The Opioid Crisis? – Dr. Mark Hyman

7 months ago

10 Psychedelics CEOs To Pay Attention To In 2022

7 months ago

Breaking the Cycle of Opioid Dependence with ibogaine

7 months ago

Goop podcast: The Future of Addiction Treatment

7 months ago

Ibogaine Therapies: Remodelling the Addicted Brain

7 months ago

Can a Shrub in Gabon Cure Addiction?

7 months ago

Dr. Deborah Mash on Why Ibogaine Treatment Aftercare is Key to Treating the Roots of Addiction

7 months ago

A Medicine that May Cure Drug Addiction: ibogaine